MAPT and Alzheimer disease: In the aforecited ADNI report [31], levels of threonine 181 p-tau in the CSF of persons with normal cognition, MCI, and AD were, respectively, 24.9 ± 14.6, 35.5 ± 18.0, and 41.6 ± 19.8 pg/ml (P < .001).